AXIC A — aXichem AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK111.41m
- SEK107.44m
- SEK18.45m
Brief: Axichem Signs Agreement With Uriach
Brief: aXichem Updates The Status Of Its Application For Feed Additive Approval For aXiphen In The EU
Brief: Axichem Gets Orders For Axivite From BART In Poland
Brief: Axichem Q1 Oper Loss Widens To SEK 3.8 Mln
Brief: aXichem Updates Status For Its EU Application For Feed Additive Approval
Brief: Axichem To Receive About SEK 34.7 Mln Through Rights Issue
Brief: aXichem Carries Out Rights Issue Of About SEK 50 Million
Brief: aXichem's Capsaicin Analogue, Axivite, To Be Launched In Three Products In U.S.
Brief: aXichem Enters Into Production Collaboration
Brief: Chr. Olesen Adds Axichem Ingredient Axiphen To Their Official Product Portfolio
Brief: Axichem Updates On Status Of EU Application For Feed Additive Approval
Brief: aXichem Jan-Sept Operating Loss Widens To SEK 12.3 Mln
Brief: Axichem Obtains Patent For Phenylcapsaicin For Use In The Treatment Of Idiopathic Pulmonary Fibrosis
Brief: aXichem Obtains New Order For aXivite
Brief: Axichem Obtains Phenylcapsaicin Patent
Brief: Axichem H1 Operating Loss Widens To SEK 8.0 Mln
Brief: Axichem Presents Promising Data From Clinical Study On Phenylcapsaicin
Brief: aXichem And Iovate Sign Supply And Research Agreement
Brief: Axichem Jan-March Operating Loss Widens To SEK 3.6 Mln